At a glance

Expected impact

Realising the Potential: The Expected Impacts of METRINO

Introduction: Shaping a New Era in Nanomedicine

The METRINO project is set to foster the clinical readiness of nanomedicine in Europe, transitioning from promising results to more systematic, impactful, real-world applications for patients. We're enabling the nanomedicine sector to flourish by providing standardised, traceable metrology that ensures the safety, efficacy, and quality of nanotherapeutics.

Key Impact Areas

1. Empowering Industry and Academia

  • Standardised measurement protocols and reference materials developed by METRINO will significantly benefit pharmaceutical companies and researchers. This includes a detailed roadmap for test and reference materials, covering diverse nanomaterials like FexOy, HfO2, LNPs, and liposomes.

2. Guiding Regulatory Frameworks

  • METRINO's contributions will provide a solid foundation for regulatory bodies, fostering clear and comprehensive guidelines for nanomedicine, ensuring patient safety and timely introduction of treatments.

3. Fostering International Collaboration

  • METRINO promotes international cooperation in nanomedicine metrology, establishing a global consensus on measurement standards and promoting harmonisation across borders.

4. Enhancing Quality Control in Nanomedicine Production

  • The project's outcomes will improve quality control processes in manufacturing, contributing to the reliability and consistency of nanotherapeutic products.

Specific Achievements and Collaborations

Development of SOPs & Analytical Methods: The METRINO consortium will provide SOPs for various analytical methods, ensuring the reliability of nanoparticle characterization.
Interlaboratory Comparisons: An internal comparison among partners, utilising techniques like SAXS, micro-CT, and electron microscopy, will lay the groundwork for external collaborations beyond the project lifetime.
Contribution to Standards: METRINO is involved in ongoing projects and envisions initiating new standardisation projects to influence international standards in nanomedicine

Stakeholder Benefits: What METRINO Means for You

Researchers, Developers, Industry

Access to validated methods and reference materials accelerates R&D and simplifies market paths.

Regulators

Reliable metrology tools for robust regulatory guidelines ensuring public safety.

Healthcare Professionals

Enhanced confidence in nanomedicine quality and efficacy, leading to better patient outcomes.

Patients

Assured safe, effective, and high-quality treatments.

Academic researchers

Implement robust SOPs in your projects and publications.

A common Vision for the Future of Nanomedicine

As METRINO progresses, we're actively shaping the future of nanomedicine. Our work promises to unlock the full potential of nanotherapeutics, heralding a new era of precision medicine. More than producing results, guidelines and knowledge, we are here to contribute to a long-lasting well educated NAnomedicine community in Europe.

Discover More About Our Community and join our journey of precision!

Metrology for Innovative Nanotherapeutics
Get Social

The METRINO project has received funding from the European Partnership on Metrology (Grant #22HLT04), co-financed from the European Union’s Horizon Europe Research and Innovation Programme and by the Participating States. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or EURAMET. Neither the European Union nor the granting authority can be held responsible for them.

© 2025 — The METRINO Project